(S)-6-Amino-N-[4-[[3-[[5-(trifluoromethyl)-2-pyridyl]oxy]phenyl]methylene]cyclohexyl]pyridine-3-carboxamide

ID: ALA4517445

Max Phase: Preclinical

Molecular Formula: C25H23F3N4O2

Molecular Weight: 468.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1ccc(C(=O)NC2CCC(=Cc3cccc(Oc4ccc(C(F)(F)F)cn4)c3)CC2)cn1

Standard InChI:  InChI=1S/C25H23F3N4O2/c26-25(27,28)19-7-11-23(31-15-19)34-21-3-1-2-17(13-21)12-16-4-8-20(9-5-16)32-24(33)18-6-10-22(29)30-14-18/h1-3,6-7,10-15,20H,4-5,8-9H2,(H2,29,30)(H,32,33)/b16-12-/t20-/m0/s1

Standard InChI Key:  UGDNJOZZYFGNIL-WNJRYGEDSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    4.1423   -4.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1412   -4.9509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8492   -5.3598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5589   -4.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5561   -4.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8474   -3.7225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4363   -3.7195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7922   -3.3479    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.2998   -2.8765    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6381   -4.0232    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.2672   -5.3579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9743   -4.9482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6793   -5.3561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3859   -4.9471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3851   -4.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6717   -3.7217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9681   -4.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0941   -5.3549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8013   -4.9455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5065   -5.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2116   -4.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2150   -4.1346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5070   -3.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7956   -4.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9238   -3.7279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6304   -4.1384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3392   -3.7317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6282   -4.9556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0447   -4.1448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7530   -3.7388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7557   -2.9207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0441   -2.5103    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3387   -2.9187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4639   -2.5131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
  1  7  1  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  1  1
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 27  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4517445

    ---

Associated Targets(Human)

FAAH Tchem Anandamide amidohydrolase (3465 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Faah Anandamide amidohydrolase (3907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.48Molecular Weight (Monoisotopic): 468.1773AlogP: 5.63#Rotatable Bonds: 5
Polar Surface Area: 90.13Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.26CX LogP: 4.69CX LogD: 4.69
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.51Np Likeness Score: -1.10

References

1. Bhuniya D, Kharul RK, Hajare A, Shaikh N, Bhosale S, Balwe S, Begum F, De S, Athavankar S, Joshi D, Madgula V, Joshi K, Raje AA, Meru AV, Magdum A, Mookhtiar KA, Barbhaiya R..  (2019)  Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.,  29  (2): [PMID:30503633] [10.1016/j.bmcl.2018.11.048]

Source